This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: L'universite Paris Descartes. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Rym Djerbi-Bouillie: Innovator in Cancer Treatment
Introduction
Rym Djerbi-Bouillie is a notable inventor based in Issy-les-Moulineaux, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic solutions.
Latest Patents
Rym holds a patent for "Polypeptides and nucleic acids for treating ErbB2-dependent cancers." This invention focuses on polypeptides, nucleic acids, and pharmaceutical compositions that are suitable for treating cancers that depend on the ErbB2 gene. Specifically, it targets tumors that overexpress ErbB2 or express mutated forms of the ErbB2 gene. Rym's work in this area is crucial for advancing treatment options for patients suffering from these types of cancers.
Career Highlights
Throughout her career, Rym has been associated with prestigious institutions such as Université Paris Descartes. Her work at these institutions has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Rym has worked alongside Sandrine Bourdoulous, a fellow researcher, to further her studies and innovations in cancer treatment. Their collaboration has been instrumental in advancing their shared goals in medical research.
Conclusion
Rym Djerbi-Bouillie is a pioneering inventor whose work in developing treatments for ErbB2-dependent cancers showcases her dedication to improving patient outcomes. Her contributions to the field of cancer research are invaluable and highlight the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile